The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
Abstract
Objective To develop a set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with hyperthyroidism and hypothyroidism. Participants Guidelines were developed by a nine-member ad hoc Standards of Care Committee of the American Thyroid Association (the authors of this article). The participants were selected by the committee chair and the president of the American Thyroid Association on the basis of their clinical experience. The committee members represented different geographic areas within the United States, in order to take into account different practice styles. Evidence Guidelines were developed on the basis of expert opinion of the participants, as well as on available published information. Consensus process Input was obtained from all of the participants, each of whom wrote an initial section of the document. A complete draft document was then written by three participants (P.A.S., D.S.C., and E.G.L.) and resubmitted to the entire committee for revision. The revised document was then submitted to the entire membership of the American Thyroid Association for written comments, which were then reviewed (mainly by P.A.S., D.S.C., and E.G.L.). Many of the suggestions of the American Thyroid Association members were incorporated into the final draft, which was then approved by the Executive Council of the American Thyroid Association. The entire process, from initial drafts to final approval, took approximately 18 m…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The options of treatment with L-T3 or the combination of L-T4 and L-T3 therefore have largely been abandoned [2,3] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [2]
Citations
Cites
Increased need for thyroxine during pregnancy in women with primary hypothyroidism
Mandel, S. J., Larsen, P. R., Seely, E. W., & Brent, G. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230204 · Cited by 360
Levothyroxine Therapy in Patients with Thyroid Disease
Mandel, S. J., Brent, G. A., & Larsen, P. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-6-199309150-00009 · Cited by 324
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“If the diagnosis is not apparent based on the clinical presentation and initial biochemical evaluation, diagnostic testing is indicated and can include, depending on available expertise and resources, (1) measurement of TRAb, (2) determination of the radioactive iodine uptake (RAIU), or (3) measurement of thyroidal bl…”
BackgroundMethodJonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
“(1) means a product (other than tobacco) that is intended to supplement the diet that bears or contains one or more of the following dietary ingredients: a vitamin, a mineral, an herb or other botanical, an amino acid, a dietary substance for use by man to supplement the diet by increasing the total dietary intake, or…”
Self-citationBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Self-citationCooper, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042972 · Cited by 1,008
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
American Thyroid Association guidelines for detection of thyroid dysfunction.
Ladenson, P., Singer, P., Ain, K., Bagchi, N., Bigos, S., Levy, E., Smith, S. A., Daniels, G., & Cohen, H. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1573 · Cited by 658
“Risk factors identifiable in personal history include (1) previous thyroid dysfunction; (2) goiter; (3) surgery or radiotherapy affecting the thyroid gland; (4) diabetes mellitus; (5) vitiligo; ( 6 ) pernicious anemia; (7) leukotrichia (prematurely gray hair); and (8) medications and other compounds, such as lithium c…”
BackgroundSelf-citation2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 427
Meier, C., Staub, J.-J., Roth, C.-B., Guglielmetti, M., Kunz, M., Miserez, A. R., Drewe, J., Huber, P., Herzog, R. F. K., & Müller-Stich, B. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7973 · Cited by 397
Flynn, R. W., Bonellie, S. R., Jung, R. T., MacDonald, T. M., Morris, A. D., & Leese, G. P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1625 · Cited by 415
Gharib, H., Tuttle, R. M., Baskin, H. J., Fish, L. H., Singer, P. A., & McDermott, M. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1231 · Cited by 394
Self-citationKeller, M. B. (2003) · JAMA · doi:10.1001/jama.289.23.3152 · Cited by 388
Gharib, H., Tuttle, R. M., Baskin, H. J., Fish, L. H., SINGER, P. A., & McDermott, M. T. (2005) · Thyroid · doi:10.1089/thy.2005.15.24 · Cited by 144
Self-citationCardiovascular and Atherogenic Aspects of Subclinical Hypothyroidism
Kahaly, G. J. (2000) · Thyroid · doi:10.1089/10507250050137743 · Cited by 310
Left Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism
Biondi, B., Fazio, S., Palmieri, E. A., Carella, C., Panza, N., Cittadini, A., Bonè, F., Lombardi, G., & Saccà, L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5733 · Cited by 334
“When the TSH level is less than 10 mU/L, the treatment may be indicated in relation to the presence of goiter or antithyroid antibodies to prevent the onset of overt hypothyroidism more than to tissue assessment of thyroid hormone deficiency (1).”
BackgroundSiegmann, E.-M., Müller, H. H. O., Luecke, C., Philipsen, A., Kornhuber, J., & Grömer, T. W. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0190 · Cited by 304
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
The Effect of Thyroid Hormone on Skeletal Integrity
Greenspan, S., & Greenspan, F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00008 · Cited by 258
Zhang, H.-Q., & Zhao, J.-J. (2009) · doi:10.3760/cma.j.issn.1673-4157.2009.04.022 · Cited by 248
Brent, G. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801880 · Cited by 592
Toft, A. D. (2001) · New England Journal of Medicine · doi:10.1056/nejmcp010145 · Cited by 229
Vanderpump, M. P. J., Ahlquist, J., Franklyn, J., & Clayton, R. (1996) · BMJ · doi:10.1136/bmj.313.7056.539 · Cited by 233
Gaitonde, D., Rowley, K. D., & Sweeney, L. (2012) · South African Family Practice · doi:10.1080/20786204.2012.10874256 · Cited by 209
Hypothyroidism: etiology, diagnosis, and management
Almandoz, J. P., & Gharib, H. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.005 · Cited by 216
Disorders of the Thyroid Gland
Pellitteri, P. K., Ing, S. W., & Jameson, B. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05283-2.00124-5 · Cited by 56
Current status and performance goals for serum thyrotropin (TSH) assays.
Spencer, C., Takeuchi, M., & Kazarosyan, M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.1.140 · Cited by 197
Werneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77588 · Cited by 184
Sawka, A. M., Gerstein, H. C., Marriott, M. J., MacQueen, G. M., & Joffe, R. T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030139 · Cited by 175
Do traditional symptoms of hypothyroidism correlate with biochemical disease?
Canaris, G. J., Steiner, J. F., & Ridgway, E. C. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.07109.x · Cited by 172
Treatment of benign nodular thyroid disease.
Hermus, A., & Huysmans, D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382007 · Cited by 165
Walsh, J. P., Ward, L. C., Burke, V., Bhagat, C. I., Shiels, L., Henley, D., Gillett, M. J., Gilbert, R., Tanner, M., & Stuckey, B. G. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0099 · Cited by 164
Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis
Nederstigt, C., Uitbeijerse, B. S., Janssen, L. G. M., Corssmit, E. P. M., de Koning, E. J. P., & Dekkers, O. M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0515 · Cited by 161
Thyroid Hormone Replacement Therapy
Wiersinga, W. M. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048140 · Cited by 150
Roos, A., Linn-Rasker, S. P., van Domburg, R. T., Tijssen, J. P., & Berghout, A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1714 · Cited by 150
“3 Thyrotropin, median (range), mIU/L 61 (14-797) 48 (11-262) .”
Chiovato, L., Fiore, E., Vitti, P., Rocchi, R., Rago, T., Dokić, D., Latrofa, F., Mammoli, C., Lippi, F., Ceccarelli, C., et al. (1998) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.83.1.4492 · Cited by 146
“ADIOIODINE (131I) is increasingly used as the definitive treatment of choice in most patients with Graves’ hyperthyroidism ( 1 , 2). After a single radioiodine administration, patients may become hypothyroid, euthyroid, or remain hyperthyroid (3).”
BackgroundCooper, D. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2003-030185 · Cited by 142
Population-based study of repeat laboratory testing.
van Walraven, C., & Raymond, M. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.021220 · Cited by 137
Psychoneuroendocrinology of mood disorders. The hypothalamic-pituitary-thyroid axis.
Hendrick, V., Altshuler, L., & Whybrow, P. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70005-8 · Cited by 135
Maggi, M., Buvat, J., Corona, G., Guay, A. T., & Torres, L. O. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02735.x · Cited by 155
Interferon-α-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects
Carella, C., Mazziotti, G., Amato, G., Braverman, L., & Roti, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0627 · Cited by 132
Effects of Evening vs Morning Levothyroxine Intake: A Randomized Double-blind Crossover Trial
Bolk, N. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.436 · Cited by 128
Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone
Ebner, R., Devoto, M., Weil, D., Bordaberry, M., Mîr, C., Martinez, H., Bonelli, L., & Nièpomniszcze, H. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.046193 · Cited by 128
Fortnightly review: Hypothyroidism: screening and subclinical disease
Weetman, A. (1997) · BMJ · doi:10.1136/bmj.314.7088.1175 · Cited by 128
Spencer, C. A., Takeuchi, M., Kazarosyan, M., Mackenzie, F., Beckett, G., & Wilkinson, E. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.3.367 · Cited by 128
Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1329 · Cited by 125
Pabla, D., Akhlaghi, F., & Zia, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.10.008 · Cited by 124
“Levothyroxine (T4), administered orally as a sodium salt, is used exclusively for thyroid replacement therapy in patients with hypothyroidism and various forms of thyroid neoplasia [1].”
BackgroundCombination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124
Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa
Hadithi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i11.1715 · Cited by 115
The history and future of treatment of hypothyroidism
McAninch, E. A., & Bianco, A. C. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1799 · Cited by 118
“In the 1995 American Thyroid Association (ATA) guidelines, biological and synthetic thyroid hormone preparations containing T4 plus T3 were not recommended out of concern for fluctuating and often elevated serum T3 concentrations (71).”
Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.014 · Cited by 118
Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114
Subclinical Thyroid Disease: A Clinician's Perspective
Cooper, D. S. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00016 · Cited by 110
“Their recommendations for checking a serum TSH level in patients who come to physicians for other reasons are consistent with those of the American Thyroid Association (3) and the American College of Pathology (4).”
The clinical content of preconception care: women with chronic medical conditions
Dunlop, A. L., Jack, B. W., Bottalico, J. N., Lu, M., James, A., Shellhaas, C., Hallstrom, L. H.-K., Solomon, B. D., Feero, W. G., Menard, M. K., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.08.031 · Cited by 102
Population screening for autoimmune thyroid disease.
Tunbridge, W. M., & Vanderpump, M. (2000) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/s0889-8529(05)70129-8 · Cited by 101
Clinical and laboratory aspects of thyroid autoantibodies
Sinclair, D. (2006) · Annals of Clinical Biochemistry · doi:10.1258/000456306776865043 · Cited by 100
High prevalence of hypothyroidism in patients with primary pulmonary hypertension.
Curnock, A. L., Dweik, R., Higgins, B., Saadi, H., & Arroliga, A. (1999) · American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40640-8 · Cited by 100
Yazici, M., Gorgulu, S., Sertbas, Y., Erbilen, E., Albayrak, S., Yildiz, O., & Uyan, C. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.05.015 · Cited by 99
“It occurs in 10–15% of the general population [1]; a particularly high prevalence is observed in women over 60 years of age; in some reports, the percentage approaches 20% of elderly women [2–4].”
BackgroundNoh, J., Yasuda, S., Sato, S., Matsumoto, M., Kunii, Y., Noguchi, Y., Mukasa, K., Ito, K., Ito, K., Sugiyama, O., et al. (2009) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2008-2700 · Cited by 96
“The American Thyroid Association guidelines mention fever and arthralgia as symptoms that occur even with MPO-ANCA-associated vasculitis, but they do not mention symptoms such as hemoptysis and urinary occult blood (or associated anemia) (12).”
BackgroundAdverse Effects of Thyroid Hormone Preparations and Antithyroid Drugs
Bartalena, L., Bogazzi, F., & Martino, E. (1996) · Drug Safety · doi:10.2165/00002018-199615010-00004 · Cited by 108
Chandrashekara, S. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.103235 · Cited by 91
“…managed either by reducing the thyroxin production at the time of hyperfunctioning or by replacing the hormone once the gland is damaged, [20] whereas in systemic diseases like SLE which targets vital organs such as kidney, etc. the primary treatment is to use immunosuppressive to…”
van Dijk, M. A. J., Reitsma, J. B., Fischer, J., & Sanders, G. T. (2003) · Clinical Chemistry · doi:10.1373/49.9.1437 · Cited by 80
Management of patients with thyroid disease
Pinto, A., & Glick, M. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0299 · Cited by 81
Are Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable?
Blakesley, V., Awni, W., Locke, C., Ludden, T., Granneman, G. R., & Braverman, L. E. (2004) · Thyroid · doi:10.1089/105072504773297867 · Cited by 85
“…most recent clinical practice guidelines from the American Association of Clinical Endocrinologists (AACE) (6) and the American Thyroid Association (7) recognize that the various brands of LT 4 have not been proven bioequiva-lent and recommend that the patient’s brand not be changed during therapy.”
Approach to the Patient with Subclinical Hyperthyroidism
Cooper, D. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2472 · Cited by 83
“American Thyroid Association (ATA) (48) No opinion American Association of Clinical Endocrinologists (AACE) (49) Periodic assessment to determine individual therapeutic options Royal College of Physicians (50) No agreement on benefits of detecting/treating SH American College of Physicians (51) No agreement on benefit…”
BackgroundTreatment Options for Graves Disease: A Cost-Effectiveness Analysis
In, H., Pearce, E. N., Wong, A. K. G., Burgess, J. F., McAneny, D. B., & Rosen, J. E. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.03.025 · Cited by 81
Fan, C., Zhou, X., Su, G., Zhou, Y., Su, J., Luo, M., & Li, H. (2019) · BMC Surgery · doi:10.1186/s12893-019-0559-8 · Cited by 97
Thyroid Hormones in Male Reproduction and Fertility
Singh, R., Hamada, A., & Agarwal, A. (2011) · The Open Reproductive Science Journal · doi:10.2174/1874255601103010098 · Cited by 77
Update on the Management of Hyperthyroidism and Hypothyroidism
Woeber, K. A. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1067 · Cited by 84
“In 1995, the American Thyroid Association published guidelines for the management of these disorders.(2) In this article, I provide an update of their management in light of more recent information.”
BackgroundMulder, J. E. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70596-4 · Cited by 87
Serrano, C. I., & Karahanna, E. (2016) · MIS Quarterly · doi:10.25300/misq/2016/40.3.04 · Cited by 72
Bini, E., & Mehandru, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.21.2371 · Cited by 73
Discontinuity of chronic medications in patients discharged from the intensive care unit
Bell, C., Rahimi-Darabad, P., & Orner, A. (2006) · Journal of general internal medicine · doi:10.1007/bf02743141 · Cited by 67
Biochemical testing of thyroid function.
Klee, G., & Hay, I. D. (1997) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/s0889-8529(05)70281-4 · Cited by 65
“[28] If these patients are not treated, yearly follow-up evaluations are recommended.”
BackgroundCancer Risk After Radioactive Iodine Treatment for Hyperthyroidism
Shim, S., Kitahara, C., Cha, E., Kim, S.-J., Ye, J.-B., & Lee, W. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25072 · Cited by 63
“Study Selection Study inclusion criteria were as follows: (1) the study population comprised patients who were diagnosed with primary cancer after RAI treatment for benign thyroid diseases, such as thyrotoxicosis and/or hyperthyroidism; (2) the interventions included the administration of RAI treatment; (3) the compar…”
MethodDayan, C., & Panicker, V. (2018) · Thyroid Research · doi:10.1186/s13044-018-0045-x · Cited by 62
Treatment of hyperthyroidism with radioactive iodine.
Kaplan, M. M., Meier, D. A., & Dworkin, H. J. (1998) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/s0889-8529(05)70307-8 · Cited by 62
Occupational pesticide exposure and subclinical hypothyroidism among male pesticide applicators
Lerro, C. C., Freeman, L. E. B., DellaValle, C. T., Kibriya, M. G., Aschebrook‐Kilfoy, B., Jasmine, F., Koutros, S., Parks, C. G., Sandler, D. P., Alavanja, M. C. R., et al. (2017) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104431 · Cited by 62
Exposure to Arsenic in urban and rural areas and effects on thyroid hormones
Ciarrocca, M., Tomei, F., Caciari, T., Cetica, C., Andrè, J., Fiaschetti, M., Schifano, M., Scala, B., Scimitto, L., Tomei, G., et al. (2012) · Inhalation Toxicology · doi:10.3109/08958378.2012.703251 · Cited by 61
“Altered carrier protein concentrations induce changes in total T4 and T3 levels, while fT4 and fT3 values exhibit little variance; thus, fT4 and fT3 measurements are more highly correlated with the thyroid status than total T4 and total T3 measurements (Singer et al., 1995).”
BackgroundThyroid Disorders in Elderly Patients
Rehman, S., Cope, D. W., Senseney, A., & Brzezinski, W. (2005) · Southern medical journal (Birmingham, Ala. Print) · doi:10.1097/01.smj.0000152364.57566.6d · Cited by 61
“Once a steady state of FTI and TSH levels has been achieved, patients should be monitored every 6 to 12 months for clinical response to the treatment, adherence to medication, and observation of drug interactions.(19) Education of the patient and family is very important, since in many elderly individuals coexisting m…”
BackgroundArterial embolization: a novel approach to thyroid ablative therapy for Graves' disease.
Xiao, H.-P., Zhuang, W., Wang, S., Yu, B.-J., Chen, G.-R., Zhou, M., & Wong, N. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.8.8723 · Cited by 61
“include: antithyroid drugs, radioiodine, or surgery (7, 8).”
The clinical importance of laboratory reasoning.
Plebani, M. (1999) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/s0009-8981(98)00196-x · Cited by 58
Wartofsky, L. (1997) · Thyroid · doi:10.1089/thy.1997.7.213 · Cited by 53
Joffe, R. T., Brimacombe, M., Levitt, A. J., & Stagnaro-Green, A. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.5.379 · Cited by 57
Salerno, M., Lettiero, T., Esposito-Del Puente, A., Esposito, V, Capalbo, D., Carpinelli, A., Padula, S., & Del Puente, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510689 · Cited by 56
Hennessey, J. V., Malabanan, A. O., Haugen, B. R., & Levy, E. G. (2010) · Endocrine Practice · doi:10.4158/ep0362.or · Cited by 56
Dissatisfaction with thyroxine therapy — could the patients be right?
Walsh, J. P. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00209-6 · Cited by 47
Vidal-Trecan, G. M., Stahl, J. E., & Eckman, M. H. (2004) · Thyroid · doi:10.1089/thy.2004.14.933 · Cited by 53
Cooper, D. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450406 · Cited by 530
Konishi, T., Okamoto, Y., Ueda, M., Fukuda, Y., Harusato, I., Tsukamoto, Y., & Hamada, N. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-262 · Cited by 52
Kraiem, Z., & Newfield, R. (2001) · Journal of Pediatric Endocrinology & Metabolism (JPEM) · doi:10.1515/jpem.2001.14.3.229 · Cited by 51
Mariani, G., Tonacchera, M., Grosso, M., Orsolini, F., Vitti, P., & Strausś, H. W. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.243170 · Cited by 77
“Learning Objectives: On successful completion of this activity, participants should be able to (1) acquire knowledge on the clinical manifestations and underlying pathophysiology of the different forms of hyperthyroidism; (2) understand how to interpret ultrasound imaging and radionuclide evaluation in patients with h…”
BackgroundThe Management of Subclinical Hyperthyroidism by Thyroid Specialists
McDermott, M. T., Woodmansee, W. W., Haugen, B. R., Smart, A., & Ridgway, E. C. (2003) · Thyroid · doi:10.1089/10507250360731532 · Cited by 45
Thyroid spermatogenesis and male infertility
Agarwal, A. K. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e292 · Cited by 46
Toxic Nodular Goiter and Cancer: A Compelling Case for Thyroidectomy
Smith, J., Chen, X., Schneider, D. F., Nookala, R., Broome, J. T., Sippel, R., Chen, H., & Solórzano, C. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2725-4 · Cited by 48
Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism
Homsanit, M., Sriussadaporn, S., Vannasaeng, S., Peerapatdit, T., Nitiyanant, W., & Vichayanrat, A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01239.x · Cited by 48
“As serum half-lives of both agents are quite short, i.e. 4±6 h for MMI and 75 minutes for PTU, it is suggested that both agents should be administered in divided daily doses (Burman, 1995; McKenzie & Zakarija, 1995; Utiger, 1995; Reed Larsen et al., 1998; Cooper, 2000).”
BackgroundCLINICAL AND LABORATORY DIAGNOSIS OF THYROTOXICOSIS
Cl, D.-A., & Surks, M. I. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70295-4 · Cited by 48
Pabla, D., Akhlaghi, F., & Zia, H. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.002 · Cited by 47
He, C.-T., Hsieh, A.-T., Pei, D., Hung, Y.-J., Wu, L.-Y., Yang, T., Lian, W., Huang, W.-S., & Kuo, S.-W. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02032.x · Cited by 47
Metadata
- Authors
- Singer, P. A.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Singer, Peter A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1995-03-08
- Volume
- 273
- Issue
- 10
- Pages
- 808
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2011275871
- Cited by
- 427
- References
- 0
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 7 · 2023: 13 · 2022: 16 · 2021: 13 · 2020: 11 · 2019: 13 · 2018: 11 · 2017: 8 · 2016: 11 · 2015: 9 · 2014: 16 · 2013: 16 · 2012: 27
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- hyperthyroidism, hypothyroidism, thyroid dysfunction, diagnosis, treatment, primary care, consensus recommendations, American Thyroid Association
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review